Pan Cancer T
PrivateLast Round
Debt
Dec 8, 2025
Total Funding Raised
$12.84M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pan Cancer T operates in Healthcare & Life Sciences and is based in Rotterdam. Its latest recorded funding round was a Debt round in December 2025.
Pan Cancer T is a biotechnology company that develops T cell receptor (TCR) T cell therapies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pan Cancer T Comparables
Compare Pan Cancer T with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affini-T Therapeutics | 83% | |
| Enara Bio | 79% | |
| Lion TCR | 76% |
For institutional investors. Book with your work email.
Pan Cancer T Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 8, 2025 | ||||
| Seed | Jul 11, 2024 | ||||
| Seed | Oct 28, 2021 | ||||
| Grant | Feb 8, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pan Cancer T Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Swanbridge Capital | Seed, Grant |
| Thuja Capital | Debt, Seed |
| Van Herk Ventures | Debt, Seed, Grant |
| InnovationQuarter | Debt, Seed |
| Health~Holland | Grant |
| Erasmus MC O&O Holding B.V. | Debt, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 408% MoM.
- May 15, 2026
Monthly visitors grew 282% MoM, reaching 447.
For institutional investors. Book with your work email.
Pan Cancer T Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pan Cancer T's valuation, stock price, and market status.
Is Pan Cancer T a public or private company?
Pan Cancer T is a private company.
What is the current stock price of Pan Cancer T?
Pan Cancer T is a private company, so its shares have no public market price. Caplight tracks Pan Cancer T's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pan Cancer T worth (valuation)?
Valuation information for Pan Cancer T is not publicly available.
Can I buy Pan Cancer T stock?
Pan Cancer T shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pan Cancer T's last funding round?
Pan Cancer T's most recent funding round was Debt on December 8, 2025.
Who are the main investors in Pan Cancer T?
Key investors in Pan Cancer T include InnovationQuarter.
Will Pan Cancer T IPO soon?
No public IPO plans have been announced for Pan Cancer T.
How can I track Pan Cancer T secondary market activity?
Caplight tracks bids, offers, and trades in Pan Cancer T's shares on secondary markets.